ArticleInternational journal of cancer2026
Maternal Thyroid Diseases, Medication Use and Childhood Cancer Risks in Offspring: A Population-Based Cohort Study in Denmark.
Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Thyroid diseases are common among women of reproductive age and may be related to childhood cancer among offspring, though the evidence is inconsistent. Using Danish registries, we conducted a population-based case-control study to investigate the relationship between maternal thyroid diseases and medication use and childhood cancer among offspring. Cases (N = 2521) diagnosed between 1973 and 2016 were ascertained from the Danish Cancer Registry, and controls (N = 63,014) were randomly selected from the Central Population Registry and matched on sex and date of birth. Information on diagnoses and prescriptions was obtained from the National Patient Register and the National Prescription Register, respectively. Conditional logistic regression was applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Goiter was associated with any cancer (OR = 2.08, 95% CI: 1.44, 3.00), leukemia (OR = 2.18, 95% CI: 1.13, 4.18), acute lymphoblastic leukemia (OR = 2.12, 95% CI: 1.02, 4.42), and lymphoma (OR = 3.06, 95% CI = 1.20, 7.82). There was no observed association between childhood cancer and maternal hypothyroidism or hyperthyroidism; however, these results were likely underpowered. No increased risk of cancer was observed for maternal thyroid medication use. Though the small sample size must be considered, the elevated risk of cancer with maternal thyroid diseases, especially goiter, was notable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.